デフォルト表紙
市場調査レポート
商品コード
1788170

骨生検システム市場レポート:2031年までの動向、予測、競合分析

Bone Biopsy System Market Report: Trends, Forecast and Competitive Analysis to 2031


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

骨生検システム市場レポート:2031年までの動向、予測、競合分析
出版日: 2025年08月08日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

骨生検システムの世界市場の将来性は、病院と診療所市場での機会により有望視されています。骨生検システムの世界市場は、2025年から2031年にかけてCAGR 5.5%で成長すると予測されます。この市場の主な促進要因は、骨疾患の有病率の増加、低侵襲手技に対する需要の高まり、先端技術の採用拡大です。

  • Lucintelの予測では、タイプ別では使い捨て生検針が予測期間中に高い成長を遂げる見込みです。
  • 用途別では、病院が高い成長が見込まれています。
  • 地域別では、APACが予測期間中に最も高い成長が見込まれます。

150ページ以上の包括的なレポートで、ビジネス上の意思決定に役立つ貴重な洞察を得られます。いくつかの洞察を含むサンプル図を以下に示します。

骨生検システム市場の新たな動向

骨生検システム業界は、様々な新興動向によって牽引されており、これらの動向は業界情勢を一変させ、技術革新を促進しています。これらの動向は、技術の進歩、低侵襲手技への移行、主要市場における規制環境の変化を反映しています。

  • 低侵襲生検技術:低侵襲生検手技は、患者の不快感や回復時間を最小限に抑えることができるため、骨生検システム市場で人気を集めています。CTガイド下針生検やロボットシステムなどの手技は、より正確で精度の高いものとして増加傾向にあります。これらの改善は、患者の転帰の改善、合併症の減少、ヘルスケア費用の削減につながります。こうした技術が病院や診療所に採用されるにつれ、医療の質は全体的に向上し、特に医療インフラが洗練された世界の先進地域における市場開拓の起爆剤となっています。
  • 診断機器の技術開発:骨生検システム市場は、CTスキャン、MRI、PETスキャンのような画像診断技術を含む診断機器の急速な開発を経験しています。これらの技術は生検検査の精度と正確性を高め、骨の疾患の早期発見を可能にしています。AIや機械学習アルゴリズムも画像解釈や意思決定を改善し、生検結果を最適化しています。診断機器の開発がさらに進むにつれて、新興国でも先進国でも採用されるようになり、高い成長を促しています。
  • ロボット支援生検システム:ロボット支援生検システムは、より優れた精度、柔軟性、生検手順の制御を提供することにより、骨生検システム市場を変革しつつあります。これらのシステムは、人為的ミスの可能性を最小限に抑え、正確なターゲティングを行い、最適な生検結果を得るためのリアルタイムイメージングを提供します。このような技術は、患者の安全性と手技の成功率を高めるため、病院や診断センターで広く採用されるようになっています。ロボットシステムは安価になり、より利用しやすくなっているため、世界的に骨生検の大量オプションになる可能性が高いです。
  • 個別化医療への動き:個別化医療への動きは骨生検システム市場でも加速しています。遺伝子プロファイリングや分子プロファイリングの向上により、生検結果は患者の個別化された遺伝子プロファイルに従って治療戦略をカスタマイズするために利用されるようになっています。個別化治療は骨疾患やがんをよりよくコントロールすることを可能にし、患者の回復によりよい機会を提供します。この動向は、新たな治療法や治療法と同様に、生検技術の革新に拍車をかけるものと思われます。
  • 新興市場におけるヘルスケア・アクセスの増加:開発途上国、特にアジア太平洋地域と中南米地域では、ヘルスケアへのアクセスが向上し、高度な診断技術への需要が高まっています。可処分所得が増加し、ヘルスケアインフラが整備されつつあるこれらの市場は、骨生検システムにとって望ましい市場となっています。急速に台頭するヘルスケアシステムのニーズに適した手頃な価格のソリューションを提供し、市場シェアを拡大するためにこれらの市場をターゲットとする企業の注目が高まっています。この動向は今後も世界の骨生検システム市場の成長を牽引していくであろう。

骨生検システム市場の新興動向は診断手技を変革し、市場開拓に拍車をかけています。低侵襲法、AI統合、ロボット対応システムの進歩により、診断精度が向上し、患者の回復時間が短縮され、患者の転帰が向上しています。さらに、個別化医療の動向と新興市場におけるヘルスケア・インフラの成長が新たな展望を生み出しています。これらの動向は、正確で外傷の少ない骨生検に対するニーズの高まりを満たすだけでなく、将来の市場成長の根拠を作り出しています。

骨生検システム市場における最近の動向

主に技術の進歩、新製品のリリース、規制の更新により、骨生検システム市場に大きな影響を与えた最近の出来事がいくつかあります。これらの出来事は、診断精度と患者の転帰を高めることに重点が置かれるようになっていることを示しています。

  • AIベースの骨生検システムの発売:AIを活用した骨生検システムの発売は業界にとって大きな出来事です。このシステムは人工知能を活用し、異常の検出と生検精度の向上を支援します。AIアルゴリズムは、医師がより迅速かつ正確に画像を確認できるよう支援し、人為的ミスの可能性を最小限に抑えます。骨生検システムにAIを組み込むことで、診断プロセスをより効率的なものに変え、再手術を最小限に抑えることができます。
  • 新規生検装置のFDA承認:最近、FDAが数々の新しい骨生検装置を承認したことで、市場が活性化し、骨の病気をより的確に診断できる最先端のツールが医療従事者に提供されるようになりました。規制当局による革新的機器の承認は、診断ソリューション強化の必要性と骨生検システム市場に対する信頼の高まりを反映しています。
  • ロボット支援骨生検システムの拡大:ロボット支援骨生検システムは、ここ数年大きな成長を遂げています。ロボット支援骨生検システムは精度が高く、人為的ミスを減らすことができるため、困難な症例における骨生検の第一選択肢となっています。このようなシステムに対する需要の伸びが、ロボット技術と関連部品の進歩を後押ししています。病院や診断センターは、生検手技をより安全で正確なものにするためにこれらのシステムを採用する傾向が強まっており、これが市場成長を全体的に後押ししています。
  • CTガイド下生検システムの採用:CTガイド下骨生検システムの採用は、骨の異常を特定する精度と効率が高いことから、ここ数年で大幅に増加しています。CT画像を用いることで、医師は生検針をポイントまで正確に導くことができ、合併症のリスクを下げ、診断結果を向上させることができます。特に病院や専門クリニックでは、こうしたシステムの使用が増加しており、骨生検の全体的な成功率と患者の満足度を押し上げています。
  • 新興市場におけるヘルスケア投資の拡大:中国やインドなど新興国におけるヘルスケア投資の拡大が、先進的骨生検システムの普及に拍車をかけています。ヘルスケアへのアクセスと可処分所得の増加に伴い、高品質の診断機器に対する需要が高まっています。世界企業はこれらの市場への進出を増やし、これらの市場の特殊なニーズに対応する高度生検システムを導入しています。ヘルスケア投資の増加は、特にアジア太平洋地域における骨生検システム市場の成長を引き続き促進すると予想されます。

骨生検システム市場における最近の大きな進歩は、技術革新のスピードとより高度な診断技術へのニーズの高まりを裏付けています。AIベースのシステム、新しい機器のFDA認可、ロボット支援システムの拡大は、骨生検の将来に革命をもたらしています。さらに、新興市場における世界の市場浸透が、新たな成長の道を切り開いています。これらの進歩は、市場が精度、自動化、アクセシビリティを追求し続けた結果です。

目次

第1章 エグゼクティブサマリー

第2章 世界の骨生検システム市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • PESTLE分析
  • 特許分析
  • 規制環境
  • 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

  • マクロ経済動向(2019年~2024年)と予測(2025年~2031年)
  • 世界の骨生検システム市場の動向(2019年~2024年)と予測(2025年~2031年)
  • 世界の骨生検システム市場:タイプ別
    • 使い捨て生検針:動向と予測(2019年~2031年)
    • 耐久性のある生検針:動向と予測(2019年~2031年)
  • 世界の骨生検システム市場:用途別
    • 病院:動向と予測(2019年~2031年)
    • クリニック:動向と予測(2019年~2031年)
    • その他:動向と予測(2019年~2031年)

第4章 2019年から2031年までの地域別市場動向と予測分析

  • 地域別世界骨生検システム市場
  • 北米の骨生検システム市場
  • 欧州の骨生検システム市場
  • アジア太平洋地域の骨生検システム市場
  • その他地域骨生検システム市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析
    • 競争企業間の敵対関係
    • 買い手の交渉力
    • 供給企業の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の骨生検システム市場におけるタイプ別成長機会
    • 用途別世界の骨生検システム市場の成長機会
    • 地域別世界骨生検システム市場の成長機会
  • 世界の骨生検システム市場における新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の骨生検システム市場の生産能力拡大
    • 世界の骨生検システム市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Stryker
  • BD
  • Merit Medical Systems
  • Argon Medical Devices
  • Teleflex
  • Instrumed Surgical
  • Medax
  • Apriomed
  • Hengrui Medical
  • Amathes
図表

List of Figures

  • Figure 2.1: Classification of the Global Bone Biopsy System Market
  • Figure 2.2: Supply Chain of the Global Bone Biopsy System Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Global Bone Biopsy System Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 3.20: Trends of the Global Bone Biopsy System Market ($B) by Type (2019-2024)
  • Figure 3.21: Forecast for the Global Bone Biopsy System Market ($B) by Type (2025-2031)
  • Figure 3.22: Trends and Forecast for Disposable Biopsy Needle in the Global Bone Biopsy System Market (2019-2031)
  • Figure 3.23: Trends and Forecast for Durable Biopsy Needle in the Global Bone Biopsy System Market (2019-2031)
  • Figure 3.24: Global Bone Biopsy System Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 3.25: Trends of the Global Bone Biopsy System Market ($B) by Application (2019-2024)
  • Figure 3.26: Forecast for the Global Bone Biopsy System Market ($B) by Application (2025-2031)
  • Figure 3.27: Trends and Forecast for Hospitals in the Global Bone Biopsy System Market (2019-2031)
  • Figure 3.28: Trends and Forecast for Clinics in the Global Bone Biopsy System Market (2019-2031)
  • Figure 3.29: Trends and Forecast for Others in the Global Bone Biopsy System Market (2019-2031)
  • Figure 4.1: Trends of the Global Bone Biopsy System Market ($B) by Region (2019-2024)
  • Figure 4.2: Forecast for the Global Bone Biopsy System Market ($B) by Region (2025-2031)
  • Figure 4.3: Trends and Forecast for the North American Bone Biopsy System Market (2019-2031)
  • Figure 4.4: North American Bone Biopsy System Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.5: Trends of the North American Bone Biopsy System Market ($B) by Type (2019-2024)
  • Figure 4.6: Forecast for the North American Bone Biopsy System Market ($B) by Type (2025-2031)
  • Figure 4.7: North American Bone Biopsy System Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.8: Trends of the North American Bone Biopsy System Market ($B) by Application (2019-2024)
  • Figure 4.9: Forecast for the North American Bone Biopsy System Market ($B) by Application (2025-2031)
  • Figure 4.10: Trends and Forecast for the United States Bone Biopsy System Market (2019-2031)
  • Figure 4.11: Trends and Forecast for the Mexican Bone Biopsy System Market (2019-2031)
  • Figure 4.12: Trends and Forecast for the Canadian Bone Biopsy System Market (2019-2031)
  • Figure 4.13: Trends and Forecast for the European Bone Biopsy System Market (2019-2031)
  • Figure 4.14: European Bone Biopsy System Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.15: Trends of the European Bone Biopsy System Market ($B) by Type (2019-2024)
  • Figure 4.16: Forecast for the European Bone Biopsy System Market ($B) by Type (2025-2031)
  • Figure 4.17: European Bone Biopsy System Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.18: Trends of the European Bone Biopsy System Market ($B) by Application (2019-2024)
  • Figure 4.19: Forecast for the European Bone Biopsy System Market ($B) by Application (2025-2031)
  • Figure 4.20: Trends and Forecast for the German Bone Biopsy System Market (2019-2031)
  • Figure 4.21: Trends and Forecast for the French Bone Biopsy System Market (2019-2031)
  • Figure 4.22: Trends and Forecast for the Spanish Bone Biopsy System Market (2019-2031)
  • Figure 4.23: Trends and Forecast for the Italian Bone Biopsy System Market (2019-2031)
  • Figure 4.24: Trends and Forecast for the United Kingdom Bone Biopsy System Market (2019-2031)
  • Figure 4.25: Trends and Forecast for the APAC Bone Biopsy System Market (2019-2031)
  • Figure 4.26: APAC Bone Biopsy System Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.27: Trends of the APAC Bone Biopsy System Market ($B) by Type (2019-2024)
  • Figure 4.28: Forecast for the APAC Bone Biopsy System Market ($B) by Type (2025-2031)
  • Figure 4.29: APAC Bone Biopsy System Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.30: Trends of the APAC Bone Biopsy System Market ($B) by Application (2019-2024)
  • Figure 4.31: Forecast for the APAC Bone Biopsy System Market ($B) by Application (2025-2031)
  • Figure 4.32: Trends and Forecast for the Japanese Bone Biopsy System Market (2019-2031)
  • Figure 4.33: Trends and Forecast for the Indian Bone Biopsy System Market (2019-2031)
  • Figure 4.34: Trends and Forecast for the Chinese Bone Biopsy System Market (2019-2031)
  • Figure 4.35: Trends and Forecast for the South Korean Bone Biopsy System Market (2019-2031)
  • Figure 4.36: Trends and Forecast for the Indonesian Bone Biopsy System Market (2019-2031)
  • Figure 4.37: Trends and Forecast for the ROW Bone Biopsy System Market (2019-2031)
  • Figure 4.38: ROW Bone Biopsy System Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.39: Trends of the ROW Bone Biopsy System Market ($B) by Type (2019-2024)
  • Figure 4.40: Forecast for the ROW Bone Biopsy System Market ($B) by Type (2025-2031)
  • Figure 4.41: ROW Bone Biopsy System Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.42: Trends of the ROW Bone Biopsy System Market ($B) by Application (2019-2024)
  • Figure 4.43: Forecast for the ROW Bone Biopsy System Market ($B) by Application (2025-2031)
  • Figure 4.44: Trends and Forecast for the Middle Eastern Bone Biopsy System Market (2019-2031)
  • Figure 4.45: Trends and Forecast for the South American Bone Biopsy System Market (2019-2031)
  • Figure 4.46: Trends and Forecast for the African Bone Biopsy System Market (2019-2031)
  • Figure 5.1: Porter's Five Forces Analysis for the Global Bone Biopsy System Market
  • Figure 6.1: Growth Opportunities for the Global Bone Biopsy System Market by Type
  • Figure 6.2: Growth Opportunities for the Global Bone Biopsy System Market by Application
  • Figure 6.3: Growth Opportunities for the Global Bone Biopsy System Market by Region
  • Figure 6.4: Emerging Trends in the Global Bone Biopsy System Market

List of Table

  • Table 1.1: Growth Rate (%, 2019-2024) and CAGR (%, 2025-2031) of the Bone Biopsy System Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Bone Biopsy System Market by Region
  • Table 1.3: Global Bone Biopsy System Market Parameters and Attributes
  • Table 3.1: Trends of the Global Bone Biopsy System Market (2019-2024)
  • Table 3.2: Forecast for the Global Bone Biopsy System Market (2025-2031)
  • Table 3.3: Attractiveness Analysis for the Global Bone Biopsy System Market by Type
  • Table 3.4: Market Size and CAGR of Various Type in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.5: Market Size and CAGR of Various Type in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.6: Trends of Disposable Biopsy Needle in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.7: Forecast for the Disposable Biopsy Needle in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.8: Trends of Durable Biopsy Needle in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.9: Forecast for the Durable Biopsy Needle in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.10: Attractiveness Analysis for the Global Bone Biopsy System Market by Application
  • Table 3.11: Market Size and CAGR of Various Application in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.12: Market Size and CAGR of Various Application in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.13: Trends of Hospitals in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.14: Forecast for the Hospitals in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.15: Trends of Clinics in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.16: Forecast for the Clinics in the Global Bone Biopsy System Market (2025-2031)
  • Table 3.17: Trends of Others in the Global Bone Biopsy System Market (2019-2024)
  • Table 3.18: Forecast for the Others in the Global Bone Biopsy System Market (2025-2031)
  • Table 4.1: Market Size and CAGR of Various Regions in the Global Bone Biopsy System Market (2019-2024)
  • Table 4.2: Market Size and CAGR of Various Regions in the Global Bone Biopsy System Market (2025-2031)
  • Table 4.3: Trends of the North American Bone Biopsy System Market (2019-2024)
  • Table 4.4: Forecast for the North American Bone Biopsy System Market (2025-2031)
  • Table 4.5: Market Size and CAGR of Various Type in the North American Bone Biopsy System Market (2019-2024)
  • Table 4.6: Market Size and CAGR of Various Type in the North American Bone Biopsy System Market (2025-2031)
  • Table 4.7: Market Size and CAGR of Various Application in the North American Bone Biopsy System Market (2019-2024)
  • Table 4.8: Market Size and CAGR of Various Application in the North American Bone Biopsy System Market (2025-2031)
  • Table 4.9: Trends of the European Bone Biopsy System Market (2019-2024)
  • Table 4.10: Forecast for the European Bone Biopsy System Market (2025-2031)
  • Table 4.11: Market Size and CAGR of Various Type in the European Bone Biopsy System Market (2019-2024)
  • Table 4.12: Market Size and CAGR of Various Type in the European Bone Biopsy System Market (2025-2031)
  • Table 4.13: Market Size and CAGR of Various Application in the European Bone Biopsy System Market (2019-2024)
  • Table 4.14: Market Size and CAGR of Various Application in the European Bone Biopsy System Market (2025-2031)
  • Table 4.15: Trends of the APAC Bone Biopsy System Market (2019-2024)
  • Table 4.16: Forecast for the APAC Bone Biopsy System Market (2025-2031)
  • Table 4.17: Market Size and CAGR of Various Type in the APAC Bone Biopsy System Market (2019-2024)
  • Table 4.18: Market Size and CAGR of Various Type in the APAC Bone Biopsy System Market (2025-2031)
  • Table 4.19: Market Size and CAGR of Various Application in the APAC Bone Biopsy System Market (2019-2024)
  • Table 4.20: Market Size and CAGR of Various Application in the APAC Bone Biopsy System Market (2025-2031)
  • Table 4.21: Trends of the ROW Bone Biopsy System Market (2019-2024)
  • Table 4.22: Forecast for the ROW Bone Biopsy System Market (2025-2031)
  • Table 4.23: Market Size and CAGR of Various Type in the ROW Bone Biopsy System Market (2019-2024)
  • Table 4.24: Market Size and CAGR of Various Type in the ROW Bone Biopsy System Market (2025-2031)
  • Table 4.25: Market Size and CAGR of Various Application in the ROW Bone Biopsy System Market (2019-2024)
  • Table 4.26: Market Size and CAGR of Various Application in the ROW Bone Biopsy System Market (2025-2031)
  • Table 5.1: Market Presence of Major Players in the Global Bone Biopsy System Market
  • Table 5.2: Operational Integration of the Global Bone Biopsy System Market
  • Table 6.1: New Product Launch by a Major Bone Biopsy System Producer (2019-2024)
目次

The future of the global bone biopsy system market looks promising with opportunities in the hospital and clinic markets. The global bone biopsy system market is expected to grow with a CAGR of 5.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of bone disorders, the rising demand for minimally invasive procedures, and the growing adoption of advanced technologies.

  • Lucintel forecasts that, within the type category, the disposable biopsy needle is expected to witness higher growth over the forecast period.
  • Within the application category, the hospital is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Bone Biopsy System Market

The bone biopsy system industry is driven by various emerging trends, which are transforming the landscape and fueling innovation. These trends are reflective of technological advancements, a move towards minimally invasive procedures, and regulatory environment shifts across major markets.

  • Minimally Invasive Biopsy Techniques: Minimally invasive biopsy procedures are gaining popularity in the bone biopsy system market because they minimize patient discomfort and recovery time. Procedures such as CT-guided needle biopsy and robotic systems are on the rise, with more precision and accuracy. These improvements lead to improved patient outcomes, fewer complications, and lower healthcare expenses. As these technologies are being embraced by hospitals and clinics, the quality of care gets better overall and catalyzes market growth, particularly in developed parts of the world with sophisticated healthcare infrastructures.
  • Technological Developments in Diagnostic Equipment: The bone biopsy systems market is experiencing rapid developments in diagnostic equipment, including imaging technologies like CT scan, MRI, and PET scan. These technologies are enhancing the accuracy and precision of biopsy tests, allowing diseases of the bones to be detected early. AI and machine learning algorithms are also improving image interpretation and decision-making, thereby optimizing biopsy outcomes. With diagnostic equipment progressing further, more will be adopted in both emerging and developed nations, prompting high growth.
  • Robotic-Assisted Biopsy Systems: Robot-assisted biopsy systems are transforming the bone biopsy system market by providing better accuracy, flexibility, and control of the biopsy procedure. These systems minimize the chances of human error, provide precise targeting, and provide real-time imaging for optimal biopsy results. Such technologies are being more widely adopted by hospitals and diagnostic centers for enhancing patient safety and procedure success rates. As robotic systems are getting cheaper and more accessible, they are likely to become a mass option for bone biopsies globally.
  • Move towards Personalized Medicine: The move towards personalized medicine is picking up pace in the market for bone biopsy systems. With improving genetic and molecular profiling, biopsy outcomes are now being employed to customize treatment strategies according to a patient's individualized genetic profile. Personalized therapies enable better control over bone diseases and cancers, providing a better opportunity for the patient's recovery. This trend is likely to fuel more innovation in biopsy technology, as well as new treatments and therapies.
  • Increasing Healthcare Access in Emerging Markets: Developing nations, especially those in the Asia-Pacific and Latin American regions, are experiencing increased access to healthcare and growing demands for sophisticated diagnostic technologies. With rising disposable incomes and advancing healthcare infrastructures, these markets have become desirable for bone biopsy systems. There is an increasing focus by companies to target these markets for tapping their market shares, providing affordable solutions suitable to the needs of rapidly emerging healthcare systems. This trend will continue to drive growth in the global bone biopsy system market.

The emerging trends in the bone biopsy system market are transforming diagnostic procedures and fueling market development. Advancements in minimally invasive methods, AI integration, and robotic-enabled systems are improving diagnostic accuracy, shortening patient recovery time, and enhancing patient outcomes. Additionally, the trend towards personalized medicine and the growing healthcare infrastructure in emerging markets are creating new prospects. These trends not only satisfy the increasing need for accurate and less traumatic bone biopsies but also create grounds for future market growth.

Recent Developments in the Bone Biopsy System Market

There are several recent events that have made a significant impact on the bone biopsy system market, primarily due to technological advancements, new product releases, and regulatory updates. These events indicate the growing emphasis on enhancing diagnostic accuracy and patient outcomes.

  • Release of AI-Based Bone Biopsy Systems: The launch of AI-driven bone biopsy systems is a major milestone for the industry. The systems utilize artificial intelligence to help detect irregularities and enhance biopsy accuracy. AI algorithms assist physicians in reviewing images more quickly and accurately, minimizing the chance of human error. Embedding AI in bone biopsy systems will transform the diagnostic process to become more efficient and minimize repeat procedures.
  • FDA Approvals for Novel Biopsy Devices: The recent FDA approvals of numerous new bone biopsy devices have stimulated the market, equipping medical professionals with cutting-edge tools to better diagnose diseases of the bone. These products, which come equipped with features like real-time imaging, needle guidance, and enhanced safety procedures, are gaining substantial interest from hospitals and clinics throughout the U.S. The approval of the innovative devices by the regulatory bodies reflects the need for enhanced diagnostic solutions and the growing faith in the bone biopsy system market.
  • Expansion of Robotic-Assisted Bone Biopsy Systems: Over the years, robotic-assisted biopsy systems have experienced considerable growth. They offer high accuracy and reduce the role of human error, and therefore, are a first-choice option for bone biopsies in challenging cases. The growth in demand for such systems is pushing the robotic technologies and allied components to advance. Hospitals and diagnostic centers are showing a growing tendency towards adopting these systems to make biopsy procedures safer and more accurate, which is overall driving the market growth.
  • Adoption of CT-Guided Biopsy Systems: The uptake of CT-guided bone biopsy systems has grown substantially over the past few years, thanks to their higher accuracy and efficiency in identifying abnormalities in bones. Using CT imaging, physicians are able to navigate biopsy needles with precision to the point, lowering the risk of complications and enhancing diagnostic results. The increasing use of these systems, especially in hospitals and specialized clinics, is driving up the overall success rate of bone biopsies and patient satisfaction.
  • Growing Healthcare Investments in Emerging Markets: Growing healthcare investments in emerging economies such as China and India are fueling the uptake of advanced bone biopsy systems. With growing healthcare access and disposable incomes, there is a rising demand for high-quality diagnostic equipment. Global companies are increasing their footprint in these markets, introducing advanced biopsy systems to meet the particular needs of these markets. Increased healthcare investment is anticipated to continue driving growth in the bone biopsy system market, particularly in the Asia-Pacific region.

Recent major advances in the bone biopsy system market underscore the speed of innovation and the growing need for more sophisticated diagnostic technologies. AI-based systems, FDA clearances for new devices, and expansion of robotic-assisted systems are revolutionizing the future of bone biopsies. Moreover, the global market penetration in the emerging markets is creating new avenues for growth. These advancements have been a result of the market's continuous move towards precision, automation, and accessibility.

Strategic Growth Opportunities in the Bone Biopsy System Market

The bone biopsy system market offers different strategic growth opportunities based on various applications. Firms can leverage these opportunities to increase their market share and enrich their portfolios.

  • Orthopedic Applications: Orthopedic use of bone biopsy systems continues to be one of the core growth segments, fueled by the rising number of bone disorders, fractures, and diseases such as osteoporosis. As the need for early and correct diagnosis increases, orthopedic clinics and hospitals are converting to high-end biopsy systems to maximize patient care. Players in this segment are likely to experience stable growth as there is a constant requirement for diagnosis in orthopedic medicine.
  • Cancer Diagnostics: Bone cancer diagnostics poses an important growth market for the bone biopsy system industry. With increasing rates of bone cancers, most importantly osteosarcoma, there is a growing demand for precise diagnostic systems. Bone biopsy systems with advanced imaging modalities and precision-guided needles are important for diagnosing bone cancers. With growing awareness of early detection, this application will experience significant market growth.
  • Infections and Inflammatory Diseases: Bone biopsy systems are critical in the diagnosis of bone infections and inflammatory diseases like osteomyelitis. With infections on the rise and the demand for precise, timely diagnosis increasing, bone biopsy systems with accuracy and less patient discomfort are in greater demand. Hospitals and clinics are increasingly investing in these systems to enhance diagnosis accuracy, making this application a significant growth opportunity for the market.
  • Rheumatoid Arthritis and Autoimmune Diseases: The increasing incidence of autoimmune diseases, such as rheumatoid arthritis, is fueling the need for bone biopsy systems. The diseases tend to cause damage and inflammation in the bones, necessitating proper diagnosis and follow-up. Bone biopsy systems play a crucial role in assessing damage severity and treatment plans. Due to the increasing rise in autoimmune diseases worldwide, the demand for biopsy systems within this application is likely to increase significantly.
  • Pediatric Applications: Pediatric usage is a new niche market for bone biopsy systems. Early diagnosis of bone ailments such as cancers and genetic disorders is extremely important for children. Pediatric biopsy systems with advanced features for use in smaller bones and less trauma are picking up steam. With enhanced emphasis on child health and more cases of pediatric cancer, this segment offers great growth opportunities for the bone biopsy system market.

Opportunities for strategic growth in the market for bone biopsy systems abound across different applications, most notably in orthopedic care, cancer diagnosis, infection control, autoimmune disease identification, and pediatric healthcare. With the prevalence of bone conditions and cancer on the increase, there is greater demand for sophisticated biopsy systems with precision and efficiency. Focusing on high-demanding applications, businesses can design their solutions to address specific market requirements and yield significant growth opportunities.

Bone Biopsy System Market Driver and Challenges

The bone biopsy system market is driven by diverse technological, economic, and regulatory drivers and challenges that affect market growth. These influences determine the competitive environment and guide product development strategies.

The factors responsible for driving the bone biopsy system market include:

1. Technological Advancements in Biopsy Systems: The ongoing technological development in biopsy systems, including the use of robotics and AI, is propelling market growth by enhancing diagnostic precision and patient outcomes.

2. Rising Incidence of Bone Disorders: With the increasing elderly population globally, the occurrence of bone disorders such as osteoporosis and cancers is on the rise, resulting in increased demand for bone biopsy systems.

3. Rising Awareness and Use of Minimally Invasive Procedures: The transition from traditional invasive diagnostic methods to minimally invasive approaches is spurring demand for bone biopsy systems that cause less pain to patients and provide quicker recovery.

4. Growth of Healthcare Infrastructure in Emerging Markets: With improving healthcare access in developing nations, the rate of adoption of cutting-edge bone biopsy systems is surging, opening up new market opportunities.

5. Supportive Reimbursement Policies: Governments in major markets are providing conducive reimbursement policies for medical equipment, boosting market growth and increasing access to sophisticated diagnostic equipment.

Challenges in the bone biopsy system market are:

1. Exorbitant Price of Sophisticated Systems: Though technology has improved, the cost of sophisticated bone biopsy systems is too high, constituting a major impediment, particularly in cost-sensitive markets such as Asia-Pacific and Africa.

2. Regulatory Challenges: Regulatory processes of approval for products, especially in developing markets, are time-consuming and cumbersome, which slows down the introduction of new products into the market and limits growth prospects.

3. Shortage of Skilled Workforce: The requirement for professionals to manage sophisticated biopsy systems is an issue, especially in developing countries where training and technical skills can be insufficient.

The bone biopsy system market is influenced by technological advancements, rising demand for minimally invasive therapies, and the development of healthcare infrastructure in emerging economies. Despite opportunities for growth, there exist high costs, regulatory barriers, and the requirement for skilled personnel. As these drivers and challenges keep changing, the market will reflect changes to address the rising demands for accurate, efficient, and affordable diagnostics.

List of Bone Biopsy System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bone biopsy system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bone biopsy system companies profiled in this report include-

  • Stryker
  • BD
  • Merit Medical Systems
  • Argon Medical Devices
  • Teleflex
  • Instrumed Surgical
  • Medax
  • Apriomed
  • Hengrui Medical
  • Amathes

Bone Biopsy System Market by Segment

The study includes a forecast for the global bone biopsy system market by type, application, and region.

Bone Biopsy System Market by Type [Value from 2019 to 2031]:

  • Disposable Biopsy Needle
  • Durable Biopsy Needle

Bone Biopsy System Market by Application [Value from 2019 to 2031]:

  • Hospitals
  • Clinics
  • Others

Bone Biopsy System Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Bone Biopsy System Market

The bone biopsy system market has been evolving rapidly due to technological advancements, growing prevalence of bone-related diseases, and increasing demand for minimally invasive diagnostic procedures. Bone biopsies are crucial in diagnosing various bone disorders, including cancers like osteosarcoma and bone infections. Markets in countries such as the United States, China, Germany, India, and Japan are witnessing significant developments, fueled by advancements in diagnostic devices, regulatory clearances, and enhanced healthcare infrastructure. These shifts are due to the growing healthcare market as well as the growing need for less invasive and more precise diagnostic procedures.

  • United States: The market for bone biopsy systems in the United States has witnessed considerable growth owing to an increase in bone cancer and orthopedic disorders. Technological developments in robotic-assisted biopsy systems and minimally invasive procedures have been a factor in the growth of the market. In addition, augmented healthcare expenditure and the use of sophisticated diagnostic technologies in hospitals and diagnostic centers are driving the growth. Government policies and FDA approvals for new biopsy systems have established a favorable market scenario for local as well as international players.
  • China: The Chinese bone biopsy system market is also growing very fast, helped by its huge population and growing incidence of bone diseases. China's government has placed an emphasis on building healthcare infrastructure and making healthcare more accessible, boosting the demand for diagnostic technology. Nevertheless, despite the market expansion, the issues of affordability, regulatory issues, and inadequate healthcare skills in some areas remain. In spite of all this, there are opportunities for growth in China's expanding middle class and health-conscious population, with foreign firms making a presence in the market.
  • Germany: Germany is among the top markets for bone biopsy systems in Europe due to high healthcare standards and innovative technology. The market is supported by robust research and development (R&D) efforts, as well as collaborations between medical device firms and research centers. German hospitals and diagnostic facilities are progressively implementing advanced bone biopsy systems to enhance diagnostic efficacy and minimize procedural-related hazards. Additionally, Germany's strong reimbursement guidelines for medical devices have supported industry growth, and it has become one of the most appealing markets for the bone biopsy market.
  • India: The bone biopsy system market in India is growing swiftly, backed by a mix of rising knowledge about bone illnesses and growing numbers of cancer cases. But cost-effective diagnostic solutions and support from the government in the form of regulatory approvals and health insurance schemes are necessary for maintaining growth in the nation. Demand for minimally invasive diagnostic equipment is increasing, particularly in urban regions where access to advanced healthcare is on the rise. Local players are being established to cater to this demand, offering affordable yet good-quality solutions.
  • Japan: Japan is experiencing consistent growth in the bone biopsy system market with a high focus on technological development and a strong, well-established health infrastructure. Japan also has the second-highest percentage of aging populations, which leads to an increased incidence of bone diseases such as osteoporosis and cancer of the bone. Japan's healthcare providers are increasingly using robotic-assisted and needle-based biopsy systems to increase patient satisfaction. Additionally, positive reimbursement policies and good emphasis on innovation have made the market competitive, attracting both local and foreign companies.

Features of the Global Bone Biopsy System Market

  • Market Size Estimates: Bone biopsy system market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Bone biopsy system market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Bone biopsy system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bone biopsy system market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bone biopsy system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bone biopsy system market by type (disposable biopsy needle and durable biopsy needle), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bone Biopsy System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: PESTLE Analysis
  • 2.4: Patent Analysis
  • 2.5: Regulatory Environment
  • 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Bone Biopsy System Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Bone Biopsy System Market by Type
    • 3.3.1: Disposable Biopsy Needle: Trends and Forecast (2019 to 2031)
    • 3.3.2: Durable Biopsy Needle: Trends and Forecast (2019 to 2031)
  • 3.4: Global Bone Biopsy System Market by Application
    • 3.4.1: Hospitals: Trends and Forecast (2019 to 2031)
    • 3.4.2: Clinics: Trends and Forecast (2019 to 2031)
    • 3.4.3: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Bone Biopsy System Market by Region
  • 4.2: North American Bone Biopsy System Market
    • 4.2.1: North American Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
    • 4.2.2: North American Market by Application: Hospitals, Clinics, and Others
    • 4.2.3: The United States Bone Biopsy System Market
    • 4.2.4: Mexican Bone Biopsy System Market
    • 4.2.5: Canadian Bone Biopsy System Market
  • 4.3: European Bone Biopsy System Market
    • 4.3.1: European Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
    • 4.3.2: European Market by Application: Hospitals, Clinics, and Others
    • 4.3.3: German Bone Biopsy System Market
    • 4.3.4: French Bone Biopsy System Market
    • 4.3.5: Spanish Bone Biopsy System Market
    • 4.3.6: Italian Bone Biopsy System Market
    • 4.3.7: The United Kingdom Bone Biopsy System Market
  • 4.4: APAC Bone Biopsy System Market
    • 4.4.1: APAC Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
    • 4.4.2: APAC Market by Application: Hospitals, Clinics, and Others
    • 4.4.3: Japanese Bone Biopsy System Market
    • 4.4.4: Indian Bone Biopsy System Market
    • 4.4.5: Chinese Bone Biopsy System Market
    • 4.4.6: South Korean Bone Biopsy System Market
    • 4.4.7: Indonesian Bone Biopsy System Market
  • 4.5: ROW Bone Biopsy System Market
    • 4.5.1: ROW Market by Type: Disposable Biopsy Needle and Durable Biopsy Needle
    • 4.5.2: ROW Market by Application: Hospitals, Clinics, and Others
    • 4.5.3: Middle Eastern Bone Biopsy System Market
    • 4.5.4: South American Bone Biopsy System Market
    • 4.5.5: African Bone Biopsy System Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bone Biopsy System Market by Type
    • 6.1.2: Growth Opportunities for the Global Bone Biopsy System Market by Application
    • 6.1.3: Growth Opportunities for the Global Bone Biopsy System Market by Region
  • 6.2: Emerging Trends in the Global Bone Biopsy System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bone Biopsy System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bone Biopsy System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Stryker
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.2: BD
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.3: Merit Medical Systems
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.4: Argon Medical Devices
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.5: Teleflex
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.6: Instrumed Surgical
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.7: Medax
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.8: Apriomed
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.9: Hengrui Medical
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.10: Amathes
    • Company Overview
    • Bone Biopsy System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing